2-[[3,4-dihydroxy-5-[(2S,3S)-3-methylpentan-2-yl]oxyoxolan-2-yl]methoxy]-6-methyloxane-3,4,5-triol
C17H32O9 — CID 162704967
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[3,4-dihydroxy-5-[(2S,3S)-3-methylpentan-2-yl]oxyoxolan-2-yl]methoxy]-6-methyloxane-3,4,5-triol
2-[[3,4-dihydroxy-5-[(2S,3S)-3-methylpentan-2-yl]oxyoxolan-2-yl]methoxy]-6-methyloxane-3,4,5-triol (PubChem CID 162704967) has the molecular formula C17H32O9 and a molecular weight of 380.43 g/mol. Its IUPAC name is 2-[[3,4-dihydroxy-5-[(2S,3S)-3-methylpentan-2-yl]oxyoxolan-2-yl]methoxy]-6-methyloxane-3,4,5-triol.
Molecular Properties
| Compound Name | 2-[[3,4-dihydroxy-5-[(2S,3S)-3-methylpentan-2-yl]oxyoxolan-2-yl]methoxy]-6-methyloxane-3,4,5-triol |
|---|---|
| PubChem CID | 162704967 |
| Molecular Formula | C17H32O9 |
| Molecular Weight | 380.43 g/mol |
| Exact Mass | 380.20 |
| IUPAC Name | 2-[[3,4-dihydroxy-5-[(2S,3S)-3-methylpentan-2-yl]oxyoxolan-2-yl]methoxy]-6-methyloxane-3,4,5-triol |
| SMILES | CC[C@H](C)[C@H](C)OC1OC(COC2OC(C)C(O)C(O)C2O)C(O)C1O |
| InChI | InChI=1S/C17H32O9/c1-5-7(2)8(3)24-17-14(21)12(19)10(26-17)6-23-16-15(22)13(20)11(18)9(4)25-16/h7-22H,5-6H2,1-4H3/t7-,8-,9?,10?,11?,12?,13?,14?,15?,16?,17?/m0/s1 |
| InChIKey | FWRWRNDIRHPPRE-ZYXXRGNTSA-N |
| XLogP | -1.27 |
| TPSA | 138.07 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 380.43 |
| LogP ≤ 5 | -1.27 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162704967 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.